186 related articles for article (PubMed ID: 10852542)
1. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.
Yan WX; Taylor J; Andrias-Kauba S; Pollard JD
Ann Neurol; 2000 Jun; 47(6):765-75. PubMed ID: 10852542
[TBL] [Abstract][Full Text] [Related]
2. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
4. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
Sung JY; Kuwabara S; Kaji R; Ogawara K; Mori M; Kanai K; Nodera H; Hattori T; Bostock H
Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of chronic inflammatory demyelinating polyneuropathy with anti-cardiolipin antibodies.
Nakajima H; Shinoda K; Doi Y; Tagami M; Furutama D; Sugino M; Kimura F; Hanafusa T
Acta Neurol Scand; 2005 Apr; 111(4):258-63. PubMed ID: 15740578
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases.
Vallat JM; Tabaraud F; Magy L; Torny F; Bernet-Bernady P; Macian F; Couratier P
Muscle Nerve; 2003 Apr; 27(4):478-85. PubMed ID: 12661050
[TBL] [Abstract][Full Text] [Related]
8. Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy.
McCombe PA; Pollard JD; McLeod JG
Clin Exp Neurol; 1988; 25():53-60. PubMed ID: 3267485
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
10. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
[TBL] [Abstract][Full Text] [Related]
11. Neurophysiological evaluation of trigeminal and facial nerves in patients with chronic inflammatory demyelinating polyneuropathy.
Kokubun N; Hirata K
Muscle Nerve; 2007 Feb; 35(2):203-7. PubMed ID: 17063459
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyneuropathy in dogs and cats.
Braund KG; Vallat JM; Steiss JE; Panangala VS; Zimmer PL
J Peripher Nerv Syst; 1996; 1(2):149-55. PubMed ID: 10975723
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
[TBL] [Abstract][Full Text] [Related]
14. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
15. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J
J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302
[TBL] [Abstract][Full Text] [Related]
16. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
17. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.
Richez C; Blanco P; Lagueny A; Schaeverbeke T; Dehais J
Neurology; 2005 Apr; 64(8):1468-70. PubMed ID: 15851749
[TBL] [Abstract][Full Text] [Related]
18. Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block.
Stubbs EB; Lawlor MW; Richards MP; Siddiqui K; Fisher MA; Bhoopalam N; Siegel GJ
Acta Neuropathol; 2003 Feb; 105(2):109-16. PubMed ID: 12536221
[TBL] [Abstract][Full Text] [Related]
19. A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP.
Echaniz-Laguna A; Degos B; Mohr M; Kessler R; Urban-Kraemer E; Tranchant C
Muscle Nerve; 2006 Mar; 33(3):356-62. PubMed ID: 16320313
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
Lewis RA
Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
